In part two of MJH Life Sciences’ three-part series, experts dissect President Trump’s most-favored nation executive order, warning that its use of tariffs and foreign price benchmarks could upend drug markets and test the limits of federal authority.
Deepika Srivastava of The Doctors Company discusses how AI is transforming medicine — and why physicians must stay engaged as the technology evolves.
Ohio State researchers say the billionaire entrepreneur’s Cost Plus Drug Company exposes how insurance premiums and middlemen drive up the true cost of neurologic medications.
To get a new tax break included in the One Big Beautiful Bill Act, some seniors need to lower their taxable income. Annuities can help do that.
Horizon Surgical Systems Polaris platform enhances precision and safety in ophthalmic procedures through AI integration.
Deepika Srivastava of The Doctors Company explains how malpractice insurers can guide physicians through the legal and clinical challenges of AI.
Kyle Zebley, senior VP of the American Telemedicine Association, joins the show to talk about the expiration of Medicare’s telehealth flexibilities during the October 2025 federal government shutdown.
A regional inspector general for the U.S. Department of Health and Human Services explains oversight of a multi-billion-dollar trend in Medicare spending.
Deepika Srivastava of The Doctors Company explains how open communication and patient consent can reduce malpractice risk when using AI tools.
A regional inspector general for the U.S. Department of Health and Human Services explains oversight of a multi-billion-dollar trend in Medicare spending.
Deepika Srivastava of The Doctors Company explains how insurers are beginning to adjust coverage as artificial intelligence tools become more common in medical practice.
Why physicians still face barriers to receiving mental health care and what’s being done to change it
Inefficient scheduling drains revenue, increases stress and frustrates patients. Here’s how to fix it before it hurts your bottom line.
Deepika Srivastava of The Doctors Company outlines the most practical steps physicians can take to mitigate legal risk when using AI tools in patient care.
Deepika Srivastava of The Doctors Company explains why the legal system is still catching up to artificial intelligence — and how future court cases could reshape malpractice law.
Understanding pain points that physicians want to solve with AI will help decision-makers choose the right AI-powered solutions for the clinical setting
Deepika Srivastava of The Doctors Company breaks down the unanswered question at the heart of AI-related malpractice: who’s responsible — the physician, the health system or the technology company?
Four other companies garner $25,000 each as finalists
Deepika Srivastava of The Doctors Company explains why the rise of AI in medicine is outpacing the legal system’s ability to manage its risks.
The top news stories in medicine today.
As spending climbs and value plummets, Trilliant Health proposes hard questions to buck negative trends.
From ease of use to real-world support, here’s what physicians should consider before committing to a new electronic health record system — and how to see how the top options compare.
A stagnant estate plan can leave physicians financially exposed and professionally stalled when career shifts, health events, or early exits disrupt the expected timeline.
To actually reach HCPs, marketers require more than just impressions. They need intent, context and compliance, all on channels natively part of the health care environment.
Study addresses equity concerns in critical care monitoring in pulse oximetry.
Three buckets to consider for your investment policy statement
Artificial intelligence is entering exam rooms faster than malpractice law can keep up. Here’s what physicians need to know about how to use these tools without inviting avoidable risk.
The Australian startup aims to scale ambient AI tool that automates administrative work in health care systems worldwide.
